Screening/Surveillance Colonoscopy Cost Measure

Identifying Attributes

Care Settings
Primary Care
Country
United States of America
Publishing Organisation
Payment program
Type of Quality Indicator
Process
IOM Quality Dimension
Efficiency
Domain
Wait and System Planning / Access

Defining Attributes

Definition

The Screening/Surveillance Colonoscopy cost measure evaluates clinicians' risk-adjusted cost to Medicare for beneficiaries who receive this procedure. The cost measure score is a clinician's average risk-adjusted cost for the episode group averaged across all episodes attributed to the clinician. This procedural measure includes costs of services that are clinically related to the attributed clinician's role in managing care from the day of the clinical event that opens or 'triggers' the episode, through 14 days after the trigger. Beneficiary populations eligible for the Screening/Surveillance Colonoscopy measure include Medicare beneficiaries enrolled in Medicare Parts A and B during the performance period.

Numerator
Denominator
Exclusions
Use of Risk Adjustment
Yes
Risk Adjustments
Stratifications

Stratification by risk category/subgroup

Data Attributes

Type of Data Collection
Administrative data
Data Collection Methods

Reporting is specific to sub-program

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025